Galileo's advanced visual analytics platform to be launched at BIO 2011 conference

Galileo Analytics announced today that it will debut Galileo Cosmos™, Galileo's advanced visual analytics platform at the BIO 2011 conference in Washington, DC, providing a powerful new dimension to Galileo's suite of analytical tools and enhancing the company's ability to mine complex sets of de-identified health data.

“There is truly nothing like this on the market today. The visual impact, along with its speed and flexibility, make this a powerful combination for data researchers. Galileo Cosmos will change the way we do data-based health research in the U.S.”

Galileo Cosmos is the first visual analytics program that enables health data researchers to quickly and flexibly analyze vast, complex sets of de-identified health data. "This interactive tool provides researchers with the ability to instantly analyze multiple data dimensions in real-time while simultaneously visualizing the results in interactive, star-like clusters of interrelated data points," said Simon Fitall, CEO of Galileo Analytics. "There is truly nothing like this on the market today. The visual impact, along with its speed and flexibility, make this a powerful combination for data researchers. Galileo Cosmos will change the way we do data-based health research in the U.S."

Cosmos links directly to and enhances the power of Galileo Telescope™, the most powerful clinical data analytics tool currently available, which enables researchers to probe an infinite number of data dimensions and patient records within minutes, cutting weeks if not months from timelines for analyzing clinical health data.

Designed to work with the electronic health record (EHR) data, the most richly detailed and complex clinical health data currently available, Galileo Cosmos and Galileo Telescope can be used to analyze an array of health data, ranging from EHR records, claims and cost data to clinical trial results.

The Most Powerful Health Data Analytics Platform Available

Combined, Galileo Telescope and Galileo Cosmos provide biopharmaceutical and public health researchers with the most advanced analytical capabilities on the market today and bring the powerful insights of the era of 'Big Data' into the health care arena. Together they provide fast, flexible ways of answering some of the most vital questions that confront the Biopharmaceutical industry today, such as:

• Informing licensing decisions through quickly analyzing current treatment landscapes
• Conducting agile sub-analyses of clinical trial data, informing critical decisions and supporting publication planning
• Enabling sophisticated analyses and reporting of post-marketing surveillance
• Providing detailed analyses of health outcomes data
• Fine-tuning marketing strategies based on real-world patient- and physician-level data